Skip to main content
  • Saved

Risk of Cardiovascular Events in Patients with Hypertriglyceridemia: A Review of Real‐World Evidence

Risk of Cardiovascular Events in Patients with Hypertriglyceridemia: A Review of Real‐World Evidence

Source : https://onlinelibrary.wiley.com/doi/abs/10.1111/dom.13921

Statin‐treated patients have substantial residual cardiovascular disease risk despite control of low‐density lipoprotein cholesterol. Other modifiable atherogenic lipids and lipoproteins, such as triglycerides and triglyceride‐rich lipoproteins, are likely responsible for some residual risk. Here we describe real‐world prevalence and consequences of hypertriglyceridemia.

Sign In or Register Today to Access This Content